CHRISTINE KENT: Open Payments
NPI 1992563993 · HAGERSTOWN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,004 in 56 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $648 · 2025 $1,004
Food & beverage: $1,004
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $244 |
| Novo Nordisk Inc | 8 | $172 |
| AstraZeneca Pharmaceuticals LP | 4 | $83 |
| Amgen Inc. | 3 | $74 |
| Lundbeck LLC | 3 | $69 |
| Lilly USA, LLC | 4 | $68 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $52 |
| Astellas Pharma US Inc | 2 | $48 |
| Otsuka America Pharmaceutical, Inc. | 3 | $44 |
| Phathom Pharmaceuticals, Inc. | 3 | $41 |
Products named: UBRELVY, Ozempic, KRYSTEXXA, REXULTI, AIRSUPRA, VRAYLAR, QULIPTA, Kerendia.
Industry payments across MD — which companies pay providers there.
